We seem to be back in the '90s, when FHFaulding's share price would go up or down with the blood pressure of the FDA board members. Hopefully another Pacman won't bounce and gobble up MYX when it was looking a bit wobbly, only to suffer acute indigestion and throw it up again a few years later.
Current management seem to have the same vision for the company as Ed Tweddell had for Faulding. The chances of failure were fairly high then, but had he been allowed to continue, the rewards were probably also high. The risks now are much the same or somewhat greater; the potential rewards may not be. The Board might want to also go back 30 years and show us "the vision thing", which, like George Bush, they seem reluctant to talk about.
MYX Price at posting:
46.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)